BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29273568)

  • 1. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy.
    Jiang DB; Zhang JP; Cheng LF; Zhang GW; Li Y; Li ZC; Lu ZH; Zhang ZX; Lu YC; Zheng LH; Zhang FL; Yang K
    Antiviral Res; 2018 Feb; 150():174-182. PubMed ID: 29273568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant DNA vaccine of Hantavirus Gn and LAMP1 induced long-term immune protection in mice.
    Jiang DB; Sun LJ; Cheng LF; Zhang JP; Xiao SB; Sun YJ; Yang SY; Wang J; Zhang FL; Yang K
    Antiviral Res; 2017 Feb; 138():32-39. PubMed ID: 27923570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein.
    Liu Y; Sun B; Pan J; Feng Y; Ye W; Xu J; Lan M; Sun H; Zhang X; Sun Y; Yang S; Shi J; Zhang F; Cheng L; Jiang D; Yang K
    Antiviral Res; 2021 Sep; 193():105141. PubMed ID: 34274417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
    Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
    J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.
    Chikhlikar P; Barros de Arruda L; Maciel M; Silvera P; Lewis MG; August JT; Marques ET
    PLoS One; 2006 Dec; 1(1):e135. PubMed ID: 17205139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine.
    Liu YY; Xu YQ; Zhong Y; Wei F; Ling JX; Li JL; Yang L; Quan FY; Chen SL; Luo F; Hou W; Yang ZQ; Chen LJ; Xiong HR
    Vaccine; 2023 Nov; 41(49):7482-7490. PubMed ID: 37953099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
    Li K; Li PY; Wu XA; Zhang L; Liu ZY; Yu L; Zhang L; Cheng LF; Bai WT; Zhang FL; Xu ZK
    Int J Mol Med; 2013 Sep; 32(3):709-16. PubMed ID: 23783439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein.
    Yang K; Sun K; Srinivasan KN; Salmon J; Marques ET; Xu J; August JT
    Gene Ther; 2009 Nov; 16(11):1353-62. PubMed ID: 19727132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen.
    Rissanen I; Krumm SA; Stass R; Whitaker A; Voss JE; Bruce EA; Rothenberger S; Kunz S; Burton DR; Huiskonen JT; Botten JW; Bowden TA; Doores KJ
    mBio; 2021 Aug; 12(4):e0253120. PubMed ID: 34225492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
    Hooper JW; Custer DM; Smith J; Wahl-Jensen V
    Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
    Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
    Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice.
    Li J; Li KN; Gao J; Cui JH; Liu YF; Yang SJ
    Vaccine; 2008 Jun; 26(25):3175-87. PubMed ID: 18479786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.
    Liu F; Liang M; Cao S; Liu Q; Zhang Q; Li C; Zhang S; Wang S; Li D
    Virol J; 2011 Sep; 8():448. PubMed ID: 21943202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response.
    Anwar A; Chandrasekaran A; Ng ML; Marques E; August JT
    Virology; 2005 Feb; 332(1):66-77. PubMed ID: 15661141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.
    Manigold T; Mori A; Graumann R; Llop E; Simon V; Ferrés M; Valdivieso F; Castillo C; Hjelle B; Vial P
    PLoS Pathog; 2010 Feb; 6(2):e1000779. PubMed ID: 20174562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.